Insider · CIK 0001620189

MANZO MICHAEL P.

Reports to the SEC for 1 company · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001620189

Forms 4 and 5

Insider transactions

46 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-08-03	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Engineering	FTax Payment	−65 sh	$2.40	−$156	15,378
2021-07-02	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Engineering	FTax Payment	−160 sh	$3.70	−$592	15,443
2021-06-04	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Engineering	FTax Payment	−155 sh	$4.19	−$649.45	15,603
2021-05-04	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Engineering	FTax Payment	−158 sh	$4.13	−$652.54	15,758
2021-04-08	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Engineering	FTax Payment	−194 sh	$4.94	−$958.36	15,916
2021-03-03	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Engineering	FTax Payment	−192 sh	$5.46	−$1,048.32	16,110
2021-02-02	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Engineering	FTax Payment	−990 sh	$6.34	−$6,276.6	16,302
2021-02-01	KPRXKIORA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	VP of Engineering	AAward	+10K sh	—	—	10,000
2021-01-04	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Engineering	FTax Payment	−115 sh	$4.85	−$557.75	17,292
2020-12-07	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Engineering	FTax Payment	−91 sh	$3.76	−$342.16	17,407
2020-11-02	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Engineering	FTax Payment	−97 sh	$3.51	−$340.47	17,498
2020-10-02	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Engineering	FTax Payment	−98 sh	$3.88	−$380.24	17,595
2020-09-02	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Engineering	FTax Payment	−97 sh	$3.94	−$382.18	17,693
2020-08-04	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Engineering	FTax Payment	−95 sh	$4.11	−$390.45	17,790
2020-07-02	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Engineering	FTax Payment	−97 sh	$4.82	−$467.54	17,885
2020-06-03	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Engineering	FTax Payment	−94 sh	$5.11	−$480.34	17,982
2020-05-05	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Engineering	FTax Payment	−93 sh	$5.10	−$474.3	18,076
2020-04-02	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Engineering	FTax Payment	−122 sh	$4.97	−$606.34	18,169
2020-03-09	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Engineering	FTax Payment	−130 sh	$5.01	−$651.3	18,291
2020-02-14	KPRXKIORA PHARMACEUTICALS INCA Award	VP of Engineering	AAward	+7,500 sh	—	—	18,421
2020-02-14	KPRXKIORA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	VP of Engineering	AAward	+7,500 sh	—	—	7,500
2020-02-04	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Engineering	FTax Payment	−109 sh	$6.00	−$654	10,921
2020-01-03	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Engineering	FTax Payment	−119 sh	$9.52	−$1,132.88	11,030
2019-12-18	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Engineering	FTax Payment	−101 sh	$7.46	−$753.46	11,149
2019-11-05	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Engineering	FTax Payment	−108 sh	$3.86	−$416.88	11,250
2019-10-09	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Engineering	FTax Payment	−185 sh	$3.13	−$579.05	11,358
2019-08-06	KPRXKIORA PHARMACEUTICALS INCF Tax Payment	VP of Engineering	FTax Payment	−1,649 sh	$0.21	−$346.29	173,147
2019-07-15	KPRXKIORA PHARMACEUTICALS INCS Sale	VP of Engineering	SSale	−6,584 sh	$0.23	−$1,534.072	174,796
2019-07-12	KPRXKIORA PHARMACEUTICALS INCS Sale	VP of Engineering	SSale	−6,583 sh	$0.24	−$1,550.955	181,380
2019-07-11	KPRXKIORA PHARMACEUTICALS INCS Sale	VP of Engineering	SSale	−6,583 sh	$0.24	−$1,583.87	187,963
2019-02-01	KPRXKIORA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	VP of Engineering	AAward	+50K sh	—	—	50,000
2018-07-10	KPRXKIORA PHARMACEUTICALS INCA Award	VP of Engineering	AAward	+175K sh	—	—	194,546
2018-02-28	KPRXKIORA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	VP of Engineering	AAward	+25K sh	—	—	25,000
2017-06-21	KPRXKIORA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	VP of Engineering	AAward	+20K sh	—	—	20,000
2017-05-18	KPRXKIORA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	VP of Engineering	AAward	+8,000 sh	—	—	8,000
2017-05-15	KPRXKIORA PHARMACEUTICALS INCM Exercise/Conversion	VP of Engineering	MExercise/Conversion	+7,285 sh	$0.65	+$4,735.25	19,546
2017-05-15	KPRXKIORA PHARMACEUTICALS INC · Stock Option (right to buy)M Exercise/Conversion	VP of Engineering	MExercise/Conversion	−7,285 sh	—	—	0
2017-02-06	KPRXKIORA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	VP of Engineering	AAward	+15K sh	—	—	15,000
2016-07-18	KPRXKIORA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	VP of Engineering	AAward	+15.6K sh	—	—	15,569
2016-03-29	KPRXKIORA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	VP of Engineering	AAward	+12K sh	—	—	12,009
2016-01-25	KPRXKIORA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	VP of Engineering	AAward	+5,000 sh	—	—	5,000
2015-08-28	KPRXKIORA PHARMACEUTICALS INCA Award	VP of Engineering	AAward	+5,926 sh	—	—	12,261
2015-08-28	KPRXKIORA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	VP of Engineering	AAward	+10K sh	—	—	10,000
2015-05-01	KPRXKIORA PHARMACEUTICALS INCA Award	VP of Engineering	AAward	+12.3K sh	—	—	12,261
2015-02-24	KPRXKIORA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	VP of Engineering	AAward	+50K sh	—	—	50,000
2015-02-19	KPRXKIORA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	VP of Engineering	AAward	+3,187 sh	—	—	52,973

Recent filings

Accepted (ET)
Aug 44
MANZO MICHAEL P.0001104659-21-100199
SEC(opens sec.gov)
Jul 64
MANZO MICHAEL P.0001104659-21-089446
SEC(opens sec.gov)
Jun 74
MANZO MICHAEL P.0001104659-21-077764
SEC(opens sec.gov)
May 54
MANZO MICHAEL P.0001104659-21-061948
SEC(opens sec.gov)
Apr 94
MANZO MICHAEL P.0001104659-21-048714
SEC(opens sec.gov)
Mar 54
MANZO MICHAEL P.0001104659-21-032764
SEC(opens sec.gov)
Feb 34
MANZO MICHAEL P.0001104659-21-011853
SEC(opens sec.gov)
Jan 54
MANZO MICHAEL P.0001104659-21-000932
SEC(opens sec.gov)
Dec 84
MANZO MICHAEL P.0001104659-20-133324
SEC(opens sec.gov)
Nov 34
MANZO MICHAEL P.0001104659-20-120949
SEC(opens sec.gov)
Oct 54
MANZO MICHAEL P.0001104659-20-112302
SEC(opens sec.gov)
Sep 34
MANZO MICHAEL P.0001104659-20-102298
SEC(opens sec.gov)
Aug 54
MANZO MICHAEL P.0001104659-20-090918
SEC(opens sec.gov)
Jul 64
MANZO MICHAEL P.0001104659-20-081225
SEC(opens sec.gov)
Jun 44
MANZO MICHAEL P.0001104659-20-069822
SEC(opens sec.gov)
May 64
MANZO MICHAEL P.0001104659-20-057471
SEC(opens sec.gov)
Apr 34
MANZO MICHAEL P.0001104659-20-043262
SEC(opens sec.gov)
Mar 104
MANZO MICHAEL P.0001104659-20-031497
SEC(opens sec.gov)
Feb 194
MANZO MICHAEL P.0001104659-20-022843
SEC(opens sec.gov)

Companies

KIORA PHARMACEUTICALS INCVP of EngineeringKPRX

Address

C/O EYEGATE PHARMACEUTICALS, INC. 271 WAVERLEY OAKS ROAD, SUITE 108

WALTHAM, MA, 02452